
Releases
GRAIL Investors File Class Action After $2.2 Billion Market Wipeout
A staggering $2.2 billion evaporated from GRAIL, Inc.’s market capitalization on February 20, 2026, after the healthcare company revealed that its high-profile NHS-Galleri trial failed to meet primary endpoints, triggering a securities class action lawsuit against the firm and its executive leadership.







.jpeg)

















